The phenomenon of ligand-induced ion channel gating hinges upon the ability of a receptor channel to bind ligand molecules with conformation-specifi c affi nities. However, our understanding of this fundamental phenomenon is notably limited, not only because the changes in binding site structure and ligand conformation that occur upon gating are largely unknown but, also, because the strength of these ligand-receptor interactions are experimentally elusive. Both high-and low-effi cacy ligands pose a number of analytical and experimental challenges that can render the estimation of their conformation-specifi c binding affi nities impossible. In this paper, we present a novel assay that overcomes some of the hurdles presented by weak agonists of the muscle nicotinic receptor and allows the estimation of their closed-state affi nities. The method, which we have termed the "activationcompetition" assay, consists of a single-channel concentration-response assay performed in the presence of a binary mixture of ligands of widely different effi cacies. By plotting the channel response (i.e., the open probability) as a function of the concentration of each agonist in the mixture, interpreting the observed response in the framework of a plausible kinetic scheme, and fi tting the open probability surface with the corresponding function, the affi nities of the closed receptor for the two agonists can be simultaneously extracted as free parameters. Here, we applied this methodology to estimate the closed-state affi nity of the muscle nicotinic receptor for choline (a very weak agonist) using acetylcholine (ACh) as the partner in the mixture. We estimated the dissociation equilibrium constant of choline (K D ) from the wild type's closed state to be 4.1 ± 0.5 mM (and that of ACh to be 106 ± 6 μM). We also discuss the use of accurate estimates of affi nities for low-effi cacy agonists as a tool to discriminate between binding and gating effects of mutations, and in the context of the rational design of therapeutic drugs.
I N T R O D U C T I O N
The nicotinic acetylcholine receptor (AChR) is activated by a variety of naturally occurring and synthetic ligands. The surge in structural information about the AChR (Brejc et al., 2001; Miyazawa et al., 2003; Celie et al., 2004) , the recognition of the involvement of nicotinic pathways in cognitive function and dysfunction (Levin and Simon, 1998; Hahn et al., 2003) , and the consistently growing repertoire of subtype-specifi c ligands with therapeutic potential (Holladay et al., 1997; Romanelli and Gualtieri 2003; Bunnelle et al., 2004) inevitably call for a parallel development of rigorous functional assays.
From a thermodynamic standpoint, the function of ligand-gated ion channels is relatively simple: the receptor channel can interconvert among a discrete number of different conformations, and each of these can bind ligands with distinct affi nities (Fig. 1) . Thus, the equilibrium constant of the closed open isomerization of the liganded form of a receptor (i.e., the "effi cacy," here denoted as θ 2 ) can be viewed as dictated by the gating equilibrium constant of the unliganded receptor (θ o ), and the ratio of the affi nities of the open (1/J D ) and the closed (1/K D ) states for the ligand in question (Monod et al., 1965; Karlin, 1967; Jackson 1984 Jackson , 1994 . In the case of a receptor with two transmitter binding sites, like the muscle AChR, we have:
Hence, a physically meaningful description of the interaction between a receptor and a ligand should be expressed in terms of conformation-specifi c liganddissociation equilibrium constants, rather than in terms of phenomenological descriptors such as EC 50 values. Since it is currently unfeasible to "trap" the protein in one of its various conformations, though, such detailed information has been diffi cult to obtain experimentally, and affi nity measurements derived from, say, equilibrium binding assays only provide a weighted average of the different conformation-specifi c affi nities.
Electrophysiological recordings provide the only experimental means to estimate conformation-specifi c affi nities of ion channels for agonists. However, classical concentration-response relationships at the singlechannel level (i.e., plots of equilibrium open probability vs. agonist concentration) and, more recently developed, global-fi tting full-maximum-likelihood methods (i.e., estimation of agonist association and dissociation rate constants from maximum-likelihood fi ts of mechanisms to dwell-time series; Qin et al., 1996; Hatton et al., 2003) have limited applicability in the case of agonists with very high or very low effi cacies. The affi nity for high-effi cacy agonists cannot be easily extracted from concentrationresponse curves because effi cacy and affi nity become increasingly correlated as the effi cacy increases (Fig. 2 A) . In these cases, affi nities cannot be easily extracted from global-fi tting methods either because the proportion of missed events increases with the effi cacy of the agonist (in the AChR, higher effi cacies are associated with faster opening rate constants; Grosman et al., 2000b) , and the ability to correct for these missed intervals has practical limits. The estimation of affi nities for low-effi cacy agonists also poses some challenges, most notably (in the case of the AChR) the narrow range of concentrations over which clusters of single-channel openings can be defi ned. This is because the small gating-equilibrium constant in the presence of low-effi cacy agonists is due to a slow opening rate constant (rather than a fast closing rate constant; Grosman, et al., 2000b) and, thus, high concentrations are needed to elicit identifi able clusters. The problem with using such high agonist concentrations is that ACh-like molecules (i.e., quaternary ammonium compounds or protonated tertiary amines) block the pore domain of the open channel often with an affi nity not much smaller than that of the closed-channel transmitter binding sites (1/K D ). As a result, the limit on the highest concentration of ligand that can be tested, set by channel block, is not much higher than the lowest concentration that is needed to elicit identifi able clusters. Moreover, the open probability (P open ) values obtained in spite of these technical diffi culties are so low that the patch-to-patch variation is often comparable to their means and are, therefore, unreliable (Fig.  2 B) . Given that low-effi cacy agonists constitute a substantial fraction of the known molecules that bind to, and activate nicotinic receptors, the lack of information about conformation-specifi c affi nities severely limits our insight into the structural determinants of binding and (liganded) gating. It is worth noting here that this important defi ciency probably extends to all neurotransmitter-gated ion channels (e.g., Erreger et al., 2004 ).
An equally important aspect of molecular recognition is the understanding of how the structure of the receptor itself, and changes to it, affects the affi nities for ligands. In many cases, the effects of mutations on the AChR's transmitter binding site affi nities are investigated by analyzing single-channel recordings elicited in the presence of ACh. However, the validity of ACh as a sensitive functional probe is questionable in the case of "gainof-function" mutants that open faster than the wild type (a very common phenotype) because the wild-type opening rate constant ‫000,05ف(‬ s −1 ) is very close to the fastest transition rate that can practically be estimated with current methods of analysis ‫000,031ف(‬ s −1 ; Burzomato et al., 2004) . In such instances, the use of low-effi cacy agonists becomes an appealing alternative (Grosman and Auerbach, 2000; Grosman et al., 2000a) . For loweffi cacy agonists to be useful in this context, however, the estimates of wild-type affi nities are required. Again, this is another good reason why the development of assays aimed at estimating conformation-specifi c affi nities for low-effi cacy agonists is of fundamental importance.
We present, here, the details of a novel single-channel based methodology, which we have termed the "activationcompetition assay," that allows the estimation of the closed state's affi nity for low-effi cacy agonists. Since one of the major hurdles is the narrow range of concentrations over which single-channel clusters can be identifi ed with these agonists, we reasoned that using a mixture of two ligands, a high-effi cacy agonist and the low-effi cacy agonist of interest, could overcome this limitation. Although low concentrations of low-effi cacy agonists fail to elicit identifi able clusters, low concentrations can be suffi cient to displace high-effi cacy ligands from the transmitter binding sites and reduce the P open in a detectable manner; this effectively widens the range of weak agonist concentrations that can be tested. By plotting the channel response (P open ) as a function of the concentration of each agonist in the (Monod et al., 1965) applied to the particular case of the (muscle) AChR. C, O, and D denote the closed, open, and desensitized conformations of the channel, respectively. In this paper, we refer to the two types of nonconductive conformations (closed and desensitized), collectively, as shut states. A denotes an agonist molecule that can bind to the neurotransmitter binding sites. The broken arrows indicate the uncertainty as to the extent to which recovery from desensitization of mono-and unliganded AChRs proceeds directly (Desensitized→Closed) or through an open-channel conformation (Desensitized→Open→ Closed). The cycle considered for arriving at Eq. 1 is displayed in bold.
binary mixture, interpreting the observed response in the framework of a plausible kinetic scheme, and fi tting the P open surface with the corresponding function, the affi nities of the closed AChR for the two agonists can be simultaneously extracted as free parameters. Here, we applied this methodology to study the activation of the adult mouse muscle AChR by its two endogenous ligands of markedly different effi cacies: ACh and choline. We estimated the dissociation equilibrium constants of ACh (K D, ACh ) and choline (K D, Choline ) from the transmitter binding sites of the wild type's closed state to be 106 ± 6 μM and 4.1 ± 0.5 mM, respectively. Also, we present an example of the use of weak (or "partial") agonists to probe the ligand binding properties of fastopening, gain-of-function mutants.
M AT E R I A L S A N D M E T H O D S
Heterologous Expression of Wild-type and S269I AChRs Adult mouse muscle AChR cDNA clones (Gardner, 1990; Sine, 1993) were provided by S.M. Sine (Mayo Clinic, Rochester, NY) in the CMV-based expression vector pRBG4 (Lee et al., 1991) . The αS269I mutation was introduced using the QuikChange Sitedirected Mutagenesis Kit (Stratagene). The complete DNA sequences of all inserts were confi rmed by dideoxy sequencing. HEK 293 cells were maintained in Dulbecco's Modifi ed Eagle Medium (Invitrogen) at 37°C in a 5% CO 2 incubator and were used for heterologous expression of wild-type and mutant AChRs. Approximately 24 h before transfection, HEK 293 cells were seeded onto 35-mm plastic culture dishes. The cells were transiently transfected using the calcium-phosphate precipitation method, the fi nal transfection mixture containing (in mM) 140 NaCl, 0.75 Na 2 HPO 4 , 125 CaCl 2 , 25 HEPES/NaOH, pH 7.05, and ‫1ف‬ μg of total cDNA per 35-mm dish. The transfection was allowed to proceed at 37°C for ‫51ف‬ h, after which the medium was changed.
Single-channel Recordings
Recordings were performed in the cell-attached confi guration (Hamill et al., 1981) at ‫°22ف‬C, ‫42ف‬ h after changing the culture medium. Patch pipettes pulled from borosilicate capillaries ( Sutter Instruments) were coated with Sylgard (Dow Corning Corporation) and fi re polished. Pipette resistances typically ranged between 8 and 10 MΩ. To maximize control on the voltage applied to the patch, a potassium-based bath solution was used. This solution, which was also used in the pipette, contained (in mM) 142 KCl, 5.4 NaCl, 1.8 CaCl 2 , 1.7 MgCl 2 , and 10 HEPES/ KOH, pH 7.4. In addition, the pipette solution contained the agonist(s) (ACh, choline, or both) at the indicated concentrations. The chloride salts of ACh and choline were obtained from Sigma-Aldrich and were used without further purifi cation. All other chemicals were obtained from Acros Organics.
For the activation-competition assay of the wild-type AChR, the concentration of ACh in the pipette solution was varied from 0 to 200 μM, whereas that of choline was varied from 0 to 50 mM ( Table I) . For the one-dimensional (1-D) concentration-response assay of the αS269I mutant, the concentration of choline in the pipette solution was varied from 200 μM to 50 mM. Unless otherwise stated, the patch pipette was held at a potential of +100 mV (i.e., the transmembrane potential was −100 mV). Single-channel currents were recorded using an Axopatch 200B amplifi er ( Molecular Devices), stored in videotape format using a PCM-VCR combination (VR-10B, f c = 37 kHz; Instrutech Corporation), and digitized at 100 kHz (National Instruments card PCI-MIO-16E-4).
Data Analysis
Preprocessing. The QuB suite of programs (www.qub.buffalo. edu) was used for data analysis, in combination with subroutines developed in-house. As a fi rst step, the digitized single-channel The different plots are concentration-response curves simulated according to the linear kinetic scheme shown in the inset (see Eq. 7). These six hypothetical high-effi cacy agonists have the same EC 50 value (20 μM) but differ in their closed-state affi nities (1/K D ) and diliganded gating equilibrium constant values (θ 2 ). Note that as the effi cacy increases (i.e., as the maximum P open approaches unity), different combinations of K D and θ 2 values make almost indistinguishable predictions. This, superimposed on the inherent patch-to-patch variation of the experimental observations, makes it impossible to simultaneously extract both parameters for high-effi cacy agonists from this type of assay. This problem would be solved if the θ 2 value of the ligand in question were known from independent experiments, so that its value can be fi xed during the fi t. However, the accurate estimation of θ 2 values for high-effi cacy agonists is not trivial. (B) These plots are also concentration-response curves simulated according to the kinetic scheme shown in the inset of A but, in this case, they correspond to four hypothetical low-effi cacy agonists with the same gating equilibrium constant (θ 2 = 0.05) and different K D values. The scatter plot superimposed on the simulated line plots corresponds to wild-type single-channel data obtained from 23 independent patches exposed to different concentrations of the low-effi cacy agonist choline (θ 2 = 0.035). Each data point corresponds to a different patch. Note that even though the four sets of simulated parameters make different predictions, the maximum P open values are small and comparable to the typical patch-to-patch variation of the P open estimates. This makes it practically impossible to extract the affi nities for weak agonists from observations of this sort. recordings were inspected visually. Sections of the data with extra noise (e.g., arising from membrane instability), with simultaneous openings of more than one channel, or with endogenous channel activity were excluded from subsequent analyses. Occasionally, some patches displayed a small fraction of clusters of openings with a P open that differed considerably from that of the mean behavior. These sections were also excluded from the present analysis. The remaining data were segmented into stretches no longer than 500 ms, and these were subjected to idealization (effective bandwidth ≅ DC-18 kHz) using a segmental k-means method based on a hidden Markov modeling procedure (SKM option in QuB; Qin, 2004) . Amplitudes of single-channel currents, as well as the mean durations of all open and shut intervals within these segments, were also estimated during the idealization step. The resulting idealized segments were concatenated such that all excluded portions of the recording were considered as baseline. This ensured that all idealized openings retained their "positions" in real time. All idealized fi les corresponding to recordings displaying stable current amplitudes were channeled into the subsequent analytical procedures.
Cluster Identifi cation. Clusters of single-channel openings were defi ned as series of openings separated by shuttings (i.e., sojourns in a nonconductive conformation) shorter than a critical time, t crit . All shuttings shorter than t crit were interpreted as sojourns in closed states, whereas all shuttings longer than t crit were interpreted as sojourns in desensitized states. However, due to the exponential nature of dwell-time distributions, no t crit value can perfectly separate "short" from "long" sojourns, and some misclassifi cation is, therefore, inevitable. This is a well-recognized problem in singlechannel analysis, and a number of approaches, which differ in the particular aspect of the misclassifi cation that is controlled, have been suggested. We chose to use the general idea behind the criterion proposed by Jackson et al. (1983) , according to which t crit is the time value that minimizes the fraction of misclassifi ed shuttings. The fraction of events that are misclassifi ed when making such a "brick-wall" cut to an exponential distribution is given by:
Fraction of misclassified events e 1 ,
where a and τ denote the areas and time constants of the dwelltime distribution, and t crit denotes the time value used to make the "cut" between the mth and the (m + 1)th components of a total of n exponential components. The t crit value that minimizes the fraction of misclassifi ed intervals in Eq. 2 can be found by numerically solving Eq. 3 (we used Maple 6.0 software; Waterloo Maple):
A modifi cation that we deemed necessary with respect to previous applications of this criterion is that, here, Eqs. 2 and 3 include the areas and time constants of all the components of the distribution, not only those of the two components fl anking the cut. Thus, the fi rst term on the righthand side of Eq. 2 gives the fraction of intervals that happen to be longer than t crit despite belonging to one of the components to the left of the cut (1 ≤ i ≤ m), whereas the second term gives the fraction of intervals that happen to be shorter than t crit despite belonging to one of the components to the right of the cut (m + 1 ≤ j ≤ n). To illustrate this procedure graphically, Eq. 2 is plotted in Fig. 3 for a shut-time distribution with simulated parameters.
Because kinetic models cannot be avoided in QuB, the parameters of the probability density function (pdf) that best describes each shut-time distribution were computed from the estimates of transition rates with approximate allowance for missed events (Qin et al., 1996) . In turn, these transition rates were estimated from maximum-likelihood fi ts to each idealized sequence of dwell times using the MIL option in QuB (Qin et al., 1996) . The kinetic schemes used in this step were not ascribed any particular physical meaning and were simply chosen so as to maximize the likelihood Figure 3 . Estimation of the critical time (t crit ) for cluster defi nition. The black line plots the fraction of misclassifi ed shuttings (Eq. 2) for a hypothetical shut-time distribution consisting of four components. The areas (a i ) and time constants (τ i ) are: a 1 = 0.7, τ 1 = 1.0 ms; a 2 = 0.15, τ 2 = 10.0 ms; a 3 = 0.1, τ 3 = 100.0 ms; and a 4 = 0.05, τ 4 = 1000.0 ms. If the cut were intended to separate shuttings belonging to component 1 from those belonging to components 2-4, then the time value that minimizes the fraction of (inevitably) misclassifi ed intervals (t crit ) can be calculated (Eq. 3) to be 4.16 ms (open circle). At t = 4.16 ms, the fraction of misclassifi ed shuttings (black line) is at the minimum value of 0.066. The red line gives the fraction of total shuttings that belong to component 1 and yet are misclassifi ed as belonging to components 2-4. The blue line gives the fraction of total shuttings that belong to components 2-4 and yet are misclassifi ed as belonging to component 1. Note that at t = t crit , the contributions of the red line and the blue line plots to the misclassifi ed fraction are different. This was also the case for all the experimentally obtained distributions analyzed in this paper.
TA B L E I

Composition of the Different Binary Mixtures of Agonists Used in the Activation-competition Assay
[ACh] (μM)
[Choline] (mM) 0 5 10 14 20 32 50 70 100 120 140 200
of the parameters. This procedure is justifi ed insofar as we are not using the transition rates themselves but the time constants and areas calculated from them. It has been shown that kinetic models that include all possible shut state open state transitions but do not allow for any shut state
shut state or open state open state transition (sometimes referred to as "uncoupled" models) can be used to obtain the best possible fi t to the idealized sequence of open and shut times (Kienker, 1989; Rothberg and Magleby, 1998; Gil et al., 2001) . However, the large number of free parameters in these models (2 × number of shut states × number of open states, without imposing any detailed balance constraint) makes the fi t with MIL (Qin et al., 1996) increasingly more diffi cult as the number of states in the kinetic scheme increases. Most notably, the maximization algorithm becomes prone to get "trapped" in local maxima, an observation made by others as well (Qin, and Li, 2004) . Empirically, we found that fi ts of our data with linear, (shut state) n (open state) m models, albeit attaining a lower maximum likelihood than uncoupled models with the same number of shut and open states, yielded areas and time constants that were very close to those obtained with the uncoupled model but were much less prone to technical problems. Hence, depending on the total number of states in the model, the transition rates of one or the other model were fi tted to the dwell-time series using the full maximum-interval-likelihood approach in QuB. The number of shut and open states that best describes the data was determined by applying the Schwarz criterion (one of several statistical criteria; Schwarz, 1978) , according to which every additional transition rate in the kinetic model is justifi ed as long as it increases the maximum log-likelihood value by at least [ln(N)]/2, where N is the total number of events in the dwell-time series after imposing the time resolution. The latter was 25 μs, for both open and shut times, for all analyzed dwell-time series. It is useful to note here that the pdf that results from applying the missed-event correction implemented in MIL (a fi rst-order approximation; Roux and Sauvé, 1985; Qin et al., 1996) to the estimated transition rates retains the form of a mixture of exponential densities with the same number of components as the perfect-resolution pdf. Fig. 4 shows examples of experimental shut-time distributions obtained over a range of ACh-choline concentrations. Since shuttime distributions were typically best described by more than two components, and because time constants attributable to sojourns in closed states are not necessarily much shorter than those attributable to dwells in desensitized conformations (especially at low agonist concentrations), the cut site was not always obvious. To facilitate this, we checked for consistency among the t crit values estimated for different patches exposed to the same agonist It can be shown that the t crit for any given distribution (open circles) coincides with the time value at which these two exponential densities intersect (Eq. 3). The sum of the red and blue lines gives, of course, the mixture of exponential densities corresponding to all the components of the distribution (bear in mind, though, that the ordinates are plotted as the square root). The t crit value, the total number of shuttings, and the fraction of misclassifi ed shuttings in these example histograms are, respectively, as follows: A: 65. 44 ms, 12,051, 0.008; B: 15.92 ms, 19,664, 0.124; C: 45.03 ms, 19,239, 0.012; D: 5.40 ms, 45,564, 0.007; E: 5.14 ms, 34,274, 0.008; F: 12.41 ms, 4,029, 0.022; G: 1.09 ms, 40,149, 0.009, H: 1.99 ms, 29,204, 0.004, I: 4.28 ms, 4,707, 0.054. solution and examined the trend in the t crit values across the range of concentrations studied. For example, at a fi xed concentration of choline (Table I) , increasing concentrations of ACh are expected to increase the (intracluster) P open and, thus, to reduce t crit . At the fi xed concentrations of ACh used here (Table I) , on the other hand, increasing concentrations of choline are expected to decrease the P open and, therefore, to increase t crit . The t crit values thus estimated were used to segment the idealized dwell-time series into clusters, but only those containing a minimum of fi ve openings (and four closures) were retained for further analysis; we found that imposing this threshold was often necessary to eliminate openings of dubious origin. Intracluster open-and shut-interval durations of any given patch were averaged to calculate their respective means (τ open and τ closed ), which, after the appropriate corrections to account for channel block, were combined to calculate the mean intracluster P open :
The reported P open values and standard errors were calculated from the means of individual patches. In Figs. 5 and 6, we present examples of single-channel clusters identifi ed using the procedures discussed above.
Corrections for Block. At some of the concentrations employed in the assay, the interaction of both ACh (≥100 μM) and choline (≥1 mM) with the channel's pore domain results in detectable channel block and in the ensuing distortion of the dwell-time distributions. In the range of ACh concentrations tested here, channel block by ACh was manifest mainly as multiple brief shuttings which, in the absence of an appropriate correction, would be erroneously interpreted as closures. To alleviate the effect of this distortion, we assumed that a time value, t block , can be defi ned such that all shuttings shorter than t block correspond to blocking events, and all shuttings longer than this threshold (but shorter than t crit ) correspond to channel closures. t block was calculated by applying Eqs. 2 and 3, assuming that most blocked sojourns are contained within the briefest shut-time component. The average t block value across patches was ‫57ف‬ μs. Next, we modifi ed the list of dwell times corresponding to the individual clusters such that all shuttings shorter than t block were "absorbed" by the fl anking open-state sojourns, in an attempt to make channel block "disappear." Dwell times within these "corrected" clusters were then used to calculate, fi rst Choline also blocks the AChR. However, individual choline block events could not be resolved as discrete shuttings (most likely owing to a much faster kinetics of binding/unbinding to/ from the pore). Instead, choline block was manifest as both, the attenuation of the single-channel current amplitude and as the prolongation of apparent open times (see Purohit and Grosman on p. 703 of this issue). The procedure followed to account for this prolongation (which, unless corrected, would have led to the overestimation of the P open ) is presented in detail in the accompanying paper (see Eqs. 6 and 7 in Purohit and Grosman, 2006) . In brief, it consisted of dividing the observed mean open-time values (τ open ) by a factor that accounts for the slower shutting rate (a factor of ‫)21ف‬ of choline-blocked channels: where F (the fractional current) is the single-channel current amplitude at each choline concentration normalized by the amplitude measured at low, nonblocking concentrations. In the case of recordings made in the presence of mixtures of ACh and choline, the two corrections were applied sequentially. Unlike the open-time distributions, the distributions of shut times were not corrected for channel block. Although the effect of block on the duration of shut intervals is more diffi cult to characterize than that on open intervals, we presented evidence ( Purohit and Grosman, 2006) for the notion that, at least in the range of choline concentrations used in these papers, the observed choline-diliganded opening rate remains quite close to its expected value at zero concentration of blocker (i.e., the opening rate constant of the choline-diliganded unblocked AChR). Therefore, a correction was deemed unnecessary.
Constructing Concentration-Response Plots.
Computed mean open (τ open ) and mean closed times (τ closed ), corrected for channel block as needed, were substituted into Eq. 4 to estimate the corresponding P open values. For the activation-competition assay, the P open was plotted as a function of the two independent variables, [ACh] and [choline] . The data were interpreted in the framework of the kinetic scheme in Fig. 7 and were fi tted with Eq. 6 (see Results) using SigmaPlot software (SPSS). The transmitter binding site affi nities of the closed wild-type AChR for the two agonists were extracted as free parameters of this fi t. In the case of the 1-D concentration-response analysis of the αS269I mutant, the plot of P open vs.
[choline] was generated. The data were fi tted with Eq. 7 (see Results), and the affi nity of the closed αS269I AChR for choline was extracted as a free parameter of the fi t.
Appraisal of the Methodology
One can defi nitely think of simpler, more direct ways of dealing with channel block. Instead of having to correct the data to account for the distorting effects of block, one could have incorporated this phenomenon into the kinetic scheme in Fig. 7 and fi tted the "crude" P open values with the corresponding function. Exactly the same could be said of our way of classifying shut intervals into closed and desensitized sojourns (for the identifi cation of clusters of single-channel openings), which has always some error associated with it. However, accounting for channel block and desensitization explicitly in the kinetic model would have implied the inclusion of, at least, six more states to the reaction scheme (three open-blocked states and three desensitized states; Fig. 7 ) and most likely many more (see below). This would have complicated Eq. 6 (by having at least six more unknowns) to a point where the unknowns of interest (i.e., the closed-state affi nities) might no longer be estimated reliably. These considerations led us to adopt the sequential approach presented here.
It could also be asked why the K D values for choline and ACh were not calculated from the rate constants of the kinetic scheme in Fig. 7 , which, in turn, could have been estimated directly by applying a full-maximum-likelihood approach to the idealized series of openings and shutting within clusters. Our reason for not doing so is that fi tting rate constants directly would have implied the use of a kinetic model that correctly accounts for block by the agonist itself. Since the closing rate constant of choline-blocked channels is not zero (i.e., a "linear" block model does not describe the data; Purohit and Grosman, 2006) , a complete kinetic scheme should include a reaction step for the association/dissociation of choline to/from the closed-channel pore (not only to/from the openchannel pore), and a step for the gating reaction of the cholineblocked channel (not only of the unblocked channel) for, at least, each diliganded confi guration of the receptor (i.e., choline diliganded, ACh diliganded, and heterodiliganded). Similarly, reaction steps should be added to represent block by ACh. Overall, this seems too complex a kinetic model for the transition rates to be estimated correctly; thus, we chose to extract P open estimates and fi t them with Eq. 6.
Recently, a full-maximum-likelihood approach (Qin et al., 1996) was applied to data recorded from the mouse muscle AChR exposed to mixtures of carbachol and choline, using a kinetic model that does not account for channel block (Akk et al., 2005) . The results from a number of patches were analyzed independently, and a different K D value for choline was estimated for each of them. The average of the estimates for the wild-type AChR was ‫3.1ف‬ mM.
R E S U LT S
The Activation-competition Assay
The activation-competition assay introduced here can be regarded as a two-dimensional version of the more common, 1-D, single-channel concentration-response curve. The experimental estimation of binding affi nities for low-effi cacy agonists poses some challenges that cannot be easily overcome using standard approaches (Fig. 2 B) . We found, however, that the use of binary mixtures of ligands containing the low-effi cacy agonist of interest and a high-effi cacy agonist (the affi nity for which need not be known) is a simple "trick" that makes the estimation of affi nities for weak agonists feasible. Fig. 8 illustrates this point graphically with simulated data. Unlike the plot in Fig. 2 B, the shape of the surface in Fig. 8 is clearly sensitive to the different affi nities of the simulated low-effi cacy agonists. Fig. 7 shows the kinetic scheme we used to interpret the activation-competition assay, and Eq. 6 is the function that describes the P open (i.e., the sum of the occupancy probabilities in OA 2 , OB 2 , and OAB) as a function of the concentrations of the two agonists in the mixture. In Eq. 6 (see above), A and B denote the concentrations of the two ligands in the mixture, K D,A and K D,B are their respective dissociation equilibrium constants from the closed-state transmitter binding sites, and θ 2 , ρ 2 , and η 2 are the gating equilibrium constants of the receptor doubly liganded with A, doubly liganded with B, or heterodiliganded (Fig. 7) .
It is important to note, here, that the kinetic scheme in Fig. 7 , and therefore Eq. 6, is based on a number of assumptions that are discussed and validated in the Discussion: (a) that the two AChR transmitter binding sites are functionally equivalent and independent (at least in terms of their K D values), (b) that unliganded and monoliganded openings of the wild-type AChR make a negligible contribution to the P open , and (c) that the gating equilibrium constant of the ACh-choline heterodiliganded receptor (η 2 ) can be calculated as the geometric mean of the respective homodiliganded gating equilibrium constants (θ 2 and ρ 2 ; Fig. 7) . Finally, desensitized states were not explicitly included in the model because sojourns in these states were considered to be excluded from the clusters of openings and closures that were fi tted with Eq. 6 (see Materials and Methods), and because the extent to which entry into desensitization shortens the lifetime of the open state is negligible in the wild-type AChR (Purohit and Grosman, 2006) . Likewise, blocked states were omitted from the scheme because their occurrence Kinetic scheme used to interpret the activationcompetition assay data. A and B denote the two agonists of different effi cacy present simultaneously during the assay. The two transmitter binding sites were assumed to have equivalent and independent K D values, whereas unliganded openings, monoliganded openings, desensitized states, and blocked states were omitted (see Discussion for a justifi cation). From the assumed equivalence and independence of the binding free energies associated to each binding site, the gating equilibrium constant of the heterodiliganded receptor was calculated as the geometric mean of the experimentally estimated effi cacies of the two agonists in the mixture. The inset shows the defi nitions of the equilibrium constants in the model. This kinetic scheme is the same as that used by Liu and Dilger (1993) to study the activation of the muscle AChR by mixtures of decamethonium and ACh although, in our case, blocked states were not included; channel block was fully accounted for separately.
was accounted for before the fi tting with Eq. 6 (see Materials and Methods).
Affi nities of the Closed Wild-type AChR for ACh and Choline
Encouraged by the simulations shown in Fig. 8 , we embarked on applying the activation-competition assay to experimental data, with the goal of estimating the affi nity of the closed-AChR's transmitter binding sites for choline, an endogenous low-effi cacy agonist. Over 50 agonist conditions were assayed (Table I) , and the corresponding intracluster P open values, averaged across different patches, were plotted as a function of the concentrations of choline and ACh (Fig. 9) . To reduce the number of free parameters in Eq. 6, we fi xed the values of the three gating equilibrium constants, (θ 2 , ρ 2 , and η 2 ; Fig. 7 ) to their independently determined values. We fi xed the value of θ 2 (ACh-diliganded gating) to 25, on the basis of recent single-channel estimates , although reported values range from 15 to 50, approximately. We fi xed ρ 2 (choline-diliganded gating) to 0.035, as determined from the ratio of the opening and closing rate constants of the choline-diliganded AChR ‫521ف(‬ s −1 and ‫009,3ف‬ s −1 , respectively; Purohit and Grosman, 2006) . Lastly, we fi xed η 2 (heterodiliganded gating) to (θ 2 ρ 2 ) 0.5 = 0.935, following the assumption that the contributions of the two transmitter binding sites to the total binding free energy are equivalent and independent of each other. To the extent that the heterodiliganded confi guration cannot be isolated from the two homodiliganded forms, and that the contribution of heterodiliganded open sojourns to the total P open is small (see Figs. 13 and 14 in Discussion), the experimental estimation of η 2 is not straightforward. Hence, we chose to calculate it.
The fi t of the 2-D concentration-response surface in Fig. 9 with Eq. 6 yielded the dissociation equilibrium constants of ACh (K D, ACh ) and choline (K D, Choline ) from the wild-type AChR's closed state. These values are 106 ± 6 μM and 4.1 ± 0.5 mM, respectively. Thus, the affi nity of the closed-state transmitter binding sites for ACh is larger than that for choline by a factor of ‫.04ف‬
To evaluate how sensitive the K D estimates are to the particular value assumed for θ 2 , we repeated the fi tting procedure assuming different θ 2 values ranging from 5 to 100. Fig. 10 shows that K D, ACh estimates depend strongly on the particular value at which θ 2 is fi xed, ranging from 30.4 μM, at θ 2 = 5, to 248 μM, at θ 2 = 100. On the other hand, however, K D, Choline estimates are fairly consistent, ranging from 3.4 mM, at θ 2 = 5, to 4.4 mM, at θ 2 = 100. We conclude that the extraction of K D values for low-effi cacy agonists, using the activationcompetition assay, is robust even if the gating equilibrium constant of the high-effi cacy partner in the mixture (which is generally diffi cult to estimate accurately) is not known with certainty.
Affi nity of the Closed αS269I AChR for Choline
Although functional studies of site-directed mutants have become the staple fare of structure-function relationships in proteins, a clear identifi cation of the functional aspect that is affected by any given mutation is rarely simple. In the particular case of ligand-gated ion channels, an increased diliganded gating equilibrium constant, for instance, could be due to an effect of the mutation on ligand binding (more specifi cally on the affi nity ratio K D /J D ) and/or on unliganded gating ( Fig. 1 and Eq. 1), and this distinction is absolutely necessary if we want to understand how structure gives rise to function.
As an example, we analyzed the αS269I AChR, a receptor harboring a mutation in the (extracellular) M2-M3 linker (Croxen et al., 1997) . Because this mutant has a gain-of-function phenotype (Croxen et al., 1997; Grosman et al., 2000a) , a high-effi cacy ligand like ACh becomes an impractical tool to probe the effect of the mutation on ligand binding (Fig. 2 A) and, instead, a weak agonist like choline may be preferred (Grosman and Auerbach, 2000) . Fig. 11 shows representative single-channel clusters of openings in the presence of increasing concentrations of choline alone. The use of binary mixtures of ligands was not necessary because the effi cacy (θ 2 ) of choline on this mutant is such that the limitations that apply to very high and very low efficacy agonists (Fig. 2) , and which prompted the development of the activation-competition assay, do not hold for this receptor-ligand pair. Fig. 12 shows the (1-D) concentration-response relationship obtained after applying the appropriate corrections for choline block to single-channel clusters identifi ed following the same procedures as for the wild type. The P open curve was fi tted with Eq. 7, the one-agonist-only version of Eq. 6. That is, Eq. 7 assumes that the two transmitter binding sites have equivalent and independent K D values, that desensitization shortens the lifetime of this mutant's open state to a negligible extent, and that the contribution of unliganded and monoliganded openings to the total P open (in the 500 μM to 50 mM choline concentration range used here) is negligible, even when the unliganded gating equilibrium constant of this mutant is larger than the wild type's (Grosman, 2003) :
where A denotes the concentration of choline, K D is the choline dissociation equilibrium constant from the closed-state transmitter binding sites, and θ 2 is the choline-diliganded gating equilibrium constant. The fi t of the 1-D concentration-response curve shown in Fig. 12 with Eq. 7 (solid black line), with both K D and θ 2 set as free parameters, yielded K D = 2.6 ± 0.5 mM and θ 2 = 2.6 ± 0.3. Thus, the ‫-57ف‬fold increase in the cholinediliganded gating equilibrium constant caused by the αS269I mutation (2.6/0.035 ≅ 74), is accompanied by only a modest change in the closed-state affi nity for choline (2.6 versus 4.1 mM). The increased θ 2 value of the mutant must then be due to a higher open-state affi nity for choline (i.e., a lower J D value) and/or a larger unliganded gating equilibrium constant ( Fig. 1 
From this expression, and remembering that for agonists K D > J D (in the case of ACh, for example, K D ≅ 100 μM, and J D should be a few nanomolar), it follows Fig. 9 , was based on a number of assumptions. Here, we tested the sensitivity of these estimates to the particular value of ACh-diliganded gating equilibrium constant (θ 2 ) assumed. We refi tted the P open vs. concentration data (Fig. 9) with θ 2 fi xed at values between 5 and 100. The values of the choline-diliganded (ρ 2 ) and the heterodiliganded (η 2 ) gating equilibrium constants remained fi xed at 0.035 and (θ 2 ρ 2 ) 0.5 , respectively, as in Fig. 9 . These plots show that the K D, ACh estimate is strongly correlated with the value at which θ 2 is fi xed (A), and that the K D, Choline estimate is, in contrast, quite robust (B). The black circles denote the K D estimates at θ 2 = 25, a very likely value for this gating equilibrium constant. The correlation between effi cacy and affi nity for ACh illustrated in A is the same correlation illustrated in the simulated 1-D concentration-response curve of Fig. 2 A for high-effi cacy agonists in general. The activation-competition assay does not overcome this problem; that is why we propose the use of this novel approach as a tool to estimate the affi nities for low-effi cacy ligands. Note the different scales on the y axes in A and B. In the inset, the y axis in B is magnifi ed. (Purohit and Grosman, 2006) , the intracluster P open "looks" higher than it actually is. that if intracluster P open values could be measured at very low agonist concentrations (comparable to or even lower than J D ), then both K D and J D values could be experimentally estimated. However, the lowest concentration of agonist that is needed to elicit identifi able clusters is generally much higher than the corresponding J D value. For instance, as much as 10 μM ACh was needed in this study to elicit clear clusters of wild-type AChR openings, and as much as 14 mM was needed in the case of choline (the J D of which should be in the micromolar range). As a result, J D + A ≅ A, and Eq. 8 becomes Eq. 7, which does not depend on J D . Hence, experimentally obtained concentration-response assays do not provide any information about the affi nity of the open-state transmitter binding sites for agonists. Similarly, the impossibility of identifying clusters of unliganded openings arising from individual channels precludes the direct estimation of the unliganded gating equilibrium constant (θ o ) from recordings made in the absence of agonist.
An alternative approach is to estimate θ o from measurements of the P open in the absence of agonist in patches with a known number of channels; this can be achieved in fast-perfused outside-out patches. Following this procedure, our estimate of θ o for the αS269I mutant is (2.3 ± 0.3) 10 −6 (unpublished data). Therefore, applying Eq. 1, J D, Choline = 2.4 μM. Thus, the affi nity of this mutant for choline increases by a factor of ‫000,1ف‬ upon opening (K D, Choline /J D, Choline = 2.6 mM/2.4 μM). However, before we can estimate the extent to which the open-state affi nity and the unliganded gating equilibrium constant are affected by the αS269I mutation, we will have to estimate the wild-type value of θ o , and then calculate the wild-type value of J D, Choline . This requires a more elaborate experimental assay because the low wild-type unliganded P open can hardly be measured under our experimental conditions.
D I S C U S S I O N
The Affi nity for Low-effi cacy Ligands: An Experimentally Elusive Parameter However paradoxical it may seem at fi rst glance, the affi nities of ligand-gated ion channels for agonists are largely unknown. As elaborated above, this is due to a number of experimental and analytical hurdles, and the main goal of this paper was, precisely, to provide a means to overcome some of these diffi culties. The activation-competition assay presented here is a novel, 2-D concentration-response assay that enables the simultaneous estimation of the affi nities of the closed-channel receptor for a pair of agonists. Although the method can, in principle, be applied to extract the K D values for the two members of the pair, we envisage that it will be particularly useful for the estimation of affi nities for low-effi cacy agonists because it is the challenges posed by the latter that are specifi cally addressed by this new approach. In the present study, we estimated the K D for choline, a low-effi cacy agonist of the AChR, using ACh as the high-effi cacy partner in the mixture.
The P open vs. concentration data were interpreted in the framework of the kinetic scheme in Fig. 7 , which is based on a set of assumptions. First, we assumed the functional equivalence and independence of the two transmitter binding sites. Although the α-δ and α-ε/γ agonist binding sites are structurally distinct, their functional equivalence (in terms of their respective K D values) continues to be an unresolved issue (e.g., Sine et al., 1990; Zhang et al., 1995; Wang et al., 1997; Salamone et al., 1999; Hatton et al., 2003) . Reports based on the application of global, maximum-likelihood fi ts to ( idealized) adult mouse muscle AChR single-channel currents (using the QuB suite of programs; Qin et al., 1996) have lately suggested that the two binding sites have indistinguishable closed-state affi nities for ACh (Salamone et al., 1999) , whereas a more recent, comparable analysis of the human counterpart (using the HJCFIT method; Colquhoun et al., 2003) suggested that the affi nities are different . The extent to which this discrepancy refl ects genuine Figure 12 . The affi nity of the αS269I AChR's closed state for choline. The K D value for choline was estimated by fi tting Eq. 7 (black solid line) to the experimental data of a 1-D concentrationresponse assay (mixtures of agonists were not necessary here). Both K D, Choline and θ 2 were set as free parameters and were estimated to be 2.6 ± 0.5 mM, and 2.6 ± 0.3, respectively. Eq. 7 assumes that both transmitter binding sites have equivalent and independent K D values. The data were also fi tted with Eqs. 10-12, and the estimated parameter values are given in Table II . Eq. 10 (red solid line) assumes that the binding sites are different and independent, Eq. 11 (blue dashed line) assumes that the binding sites are equivalent and interacting, and Eq. 12 assumes that the binding sites are different and interacting. The fi ts with these three expressions are almost indistinguishable. The fi t with Eq. 12 (not shown for clarity) yielded K D estimates that were very sensitive to the initial guesses and were very poorly defi ned (i.e., the coeffi cients of variation were very large). Vertical error bars are standard errors.
differences between species or differences in the analytical methods employed remains an open question. In the particular case of our activation-competition assay, the assumption of equivalence and independence of the transmitter binding sites turned out to be convenient because it reduces the number of free parameters in Eq. 6 to a manageable level. But if the sites were neither equivalent nor independent of one another, what are we measuring then? For simplicity, we tested the equivalence/independence assumption on the concentration-response data gathered from the αS269I mutant activated (only) by choline. The results of fi tting the four possible models (equivalent/independent, equivalent/interacting, different/independent, and different/interacting; see Appendix) are shown in Fig.  12 and Table II . We conclude that, for all four models, a set of parameters can be found that describes very closely the equilibrium concentration-response curve of the αS269I AChR. Under the assumption of equivalence and independence, though, the model is simplest, and the parameter estimates are most uniquely defi ned. It is evident that observables other than the P open , more sensitive to the different predictions made by the different models, need to be analyzed before we can settle this vexed question on the basis of a criterion more compelling than that of parsimony. It is our impression that the application of global-fi tting maximum-likelihood methods has not been completely successful in this regard either.
Second, we ignored the occurrence of unliganded and monoliganded openings. This is justifi ed because in the wild-type, the corresponding gating equilibrium constants are so small that the contribution of sojourns in the unliganded or monoliganded open states to the total P open is negligible at the concentrations of agonist used here to elicit clusters. Even in the absence of a fi rm estimate, the θ o value of the wild-type AChR can be safely assumed to be in the 10 −7 -10 −8 range. From Fig. 1 , then, the ACh-monoliganded θ 1 value (θ 1 = [θ 0 θ 2 ] 0.5 ) should be close to 10 −3 , whereas the choline-monoliganded θ 1 value should be in the 10 −4 -10 −5 range. These values are, indeed, small.
Finally, the gating equilibrium constant of the AChcholine heterodiliganded receptor (η 2 ) was fi xed to the geometric mean of the respective homodiliganded gating equilibrium constants (θ 2 and ρ 2 ). When η 2 was allowed to vary during the fi tting procedure, the free parameters were estimated to be: K D, ACh = 108 ± 6 μM, K D, Choline = 2.3 ± 0.7 mM, and η 2 = 3.1 ± 1.0. Reassuringly, these values compare well with the estimates of K D, ACh = 106 ± 6 μM and K D, Choline = 4.1 ± 0.5 mM, obtained with η 2 constrained to its calculated value of 0.935. However, because we fi nd no obvious evidence for deviations from the assumption of equivalence and independence of the two transmitter binding sites (in terms of their contributions to the total binding free energy), we take 106 ± 6 μM and 4.1 ± 0.5 mM as the ACh and choline dissociation equilibrium constants, respectively, from the wild-type AChR in the closed state. It is likely that the difference between the calculated and fi tted values of η 2 refl ects the inherent inaccuracies of the experimental data, and the notion that heterodiliganded receptors do not contribute much to the observed P open . Figs. 13 and 14 illustrate the contribution of the heterodiliganded and the two homodiliganded forms of the receptor to the total P open .
Conformation-specifi c Affi nities: Basic and Applied Implications
Understanding the structural basis of a ligand's differential binding to the open and closed forms of a receptor channel represents a large fraction of all we need to know to understand diliganded gating; the rest is unliganded gating. Thus, it is of obvious importance to be able to obtain accurate estimates of conformation-specifi c affi nities. We envision that continued application of the activation-competition assay (to estimate K D values), along with fi rm estimates of wild-type and mutant unliganded gating equilibrium constants (to calculate J D values), will pave our way toward this paramount goal.
In this paper, we focused on ACh and choline. From their respective θ 2 estimates, it can be inferred (Eq. 1) that the increase in affi nity for choline upon opening is smaller than that for ACh by a factor of ‫52ف‬ ([θ 2, ACh / θ 2, Choline ] 0.5 ). Because the affi nity of the AChR's closed state (1/K D ) for choline is lower than that for ACh by a factor of ‫04ف‬ (K D, Choline /K D, ACh ), it follows that the From a more practical perspective, we anticipate that improved methodologies to estimate conformationspecifi c affi nities will contribute to further rationalize the process of structure-based drug design in, at least, two ways: fi rst, by providing benchmark affi nity values against which the robustness of computational approaches aimed at predicting ligand-protein binding affi nities (Morreale et al., 2002; Oostenbrink and van Gunsteren, 2005; Woo and Roux, 2005) can be tested; and second, by providing a "library" of K D , J D , and efficacy values (θ 2 ) that can guide efforts in medicinal chemistry toward the design of ligands with the desired properties (Holladay et al., 1997) . In this respect, however, a caveat is in order: what does an experimentally estimated K D value really measure? What happens during a ligand association/dissociation reaction? It is almost certain that binding reactions not only consist of the docking of a ligand to a binding site but, also, involve local rearrangements in the protein, and changes in the conformation of the ligand, that precede the more global conformational change that accompanies gating. Thus, an experimentally obtained K D value would be the equilibrium constant of this complex reaction, which, at least in the muscle AChR, can still be kinetically modeled as a one-step event (e.g., Salamone et al., 1999; Hatton et al., 2003 ; but see Burzomato et al., 2004 , for a probably different situation in the α1β glycine receptor). It is obvious, then, that for computational approaches to make accurate predictions of measured binding affi nities, the conformational fl exibility of both protein and ligand needs to be fully accounted for in the algorithms. This is not an easy task, however, and constitutes one of the major roadblocks on the way toward the computer-aided rational design of drugs (Teague, 2003) .
Low-effi cacy Agonists as Tools in Structure-Function Studies
Although the functional consequences of mutations to ligand-gated ion channels are typically classifi ed into "binding" or "gating" effects, we think that it is more sensible to distinguish among effects on the closedstate affi nity, the open-state affi nity, or the unligandedgating equilibrium constant (Eq. 1). Also, although most functional studies of AChR mutants use ACh as the ligand (with the understandable justifi cation that ACh is the natural agonist of this receptor), we think that low-effi cacy agonists, like choline, offer some important advantages in the case of fast-opening mutants. In the specifi c case of the αS269I mutation studied here, we can conclude that the closed-state affi nity for choline remains practically the same upon mutation (2.6 ± 0.5 mM in the mutant and 4.1 ± 0.5 mM in the wild type). If the open-state affi nity also remained largely unaffected by the mutation, then the increase in the choline-diliganded gating equilibrium constant of the αS269I AChR (2.6 in the mutant and 0.035 in the wild type) would be entirely due to the increased unliganded activity (Eq. 1) reported earlier for this mutant (Grosman, 2003) . However, because it is still not known how to predict changes in J D on the basis of measured changes in K D , we cannot offer a more complete description of what goes wrong upon the αS269I mutation, at this point. Indeed, what we need to revert this situation is a robust estimate of the wild-type unliganded gating equilibrium constant.
In spite of the many available weak agonists of the AChR, only choline seems to have met the requirements for a convenient functional probe of gain-of-function mutations, thus far. That is, high solubility, structural resemblance to ACh, manageable channel block, and binding/gating properties that can be reliably quantifi ed in the wild-type receptor. It may be noted that some mutations may speed up opening to such an extent that choline may no longer be a useful probe. It is evident that to address these important cases, a wider repertoire of well-characterized low-effi cacy agonists is needed.
A P P E N D I X
We tested the assumption that the two AChR transmitter binding sites are functionally equivalent and independent (in terms of their K D values) by fi tting the αS269I-choline one-dimensional single-channel P open curve with the four possible models. We tested this assumption on the αS269I mutant, rather than on the wild type, because the interaction between this mutant and choline can be characterized with a simple 1-D concentration-response relationship (Fig. 12) , which greatly facilitates the analysis.
For a receptor with two binding sites, and in the presence of a single ligand, the most general kinetic scheme (omitting unliganded openings, monoliganded openings, and desensitized and blocked states) is given in Fig. 15 . The properties of equivalence and independence of the transmitter binding sites can be combined to give rise to four models, each of which is characterized by a different P open expression.
If the two binding sites are equivalent and independent, then (Fig. 15 ) K D1 = K D2 = K D3 = K D4 = K D , and the P open (here, P AOA ) is given by:
where A denotes the ligand concentration, and θ 2 is the diliganded gating equilibrium constant. Eq. 9 is, of course, simply another way of writing Eq. 7, but this form is useful for comparison with the expressions corresponding to the models below. If the two binding sites are different and independent, then K D1 = K D4 = K DA and K D2 = K D3 = K DB , and the P open is given by:
where K DA and K DB are the ligand dissociation equilibrium constants from either binding site regardless of whether both or only one site is occupied. 
where K MONO is the ligand dissociation equilibrium constant from either monoliganded receptor confi guration (both confi gurations are equivalent), and K DOUBLY is the ligand dissociation equilibrium constant from either site of the diliganded receptor. Finally, if the two binding sites are different and interacting, the P open is given by:
where K D4 is expressed in terms of K D1 , K D2 , and K D3 (K D4 = K D1 K D3 /K D2 , from detailed balance). The parameter estimates obtained using Eq. 12 (i.e., assuming that the binding sites are different and interacting) were very sensitive to the initial guesses, and the three K D estimates (here, K D1 , K D2 , and K D3 ) had very large coeffi cients of variation. The results of fi tting the data with the other three models, using Eqs. 9-11, are summarized in Fig. 12 and Table II. We thank Sergio Elenes and Ying Ni for help with some electrophysiology experiments, Daniel Chang for software development, and Jagoda Jasielec and Jessica Gasser for assistance with cell culture and molecular biology.
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